Metabolomic and Cellular Inflammaging Investigation Study of Patients With Acute Coronary Syndrome (ACS)
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The prospective experimental study aims to take an instantaneous photograph of the subject at time T0 and after 24 hours of intestinal permeability and dysbiosis indices in patients with acute coronary syndromes (ACS) which include unstable coronary artery disease (unstable angina) and acute myocardial infarction (AMI). The aim is to verify whether essential oils in particular formulations with high bioavailability are able to re-establish intestinal eubiosis after 2 months, confirmed by tests laboratory specifics such as metabolomics.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 70
Healthy Volunteers: f
View:
• 1\. Signing of informed consent
• 2\. Diagnosis of Acute Coronary Syndrome (ACS)
• 3\. Age 30-70
Locations
Other Locations
Italy
Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
RECRUITING
Peschiera Del Garda
Time Frame
Start Date: 2026-03
Estimated Completion Date: 2027-03
Participants
Target number of participants: 15
Treatments
Other: non-pharmacological therapy arm
after discharge from the experimental center the subject will be prescribed drug therapy, as directed by the medical experimenter, and non-drug therapy.~For the next 2 months, in addition to conventional therapy, each individual will be combined with non-pharmacological therapy consisting of essential oils and a post- and prebiotic component.
Related Therapeutic Areas
Sponsors
Collaborators: Herboplanet Srl
Leads: Casa di Cura Dott. Pederzoli